Diagenode

LGC will supply DNA fragmentation instruments for clinical and agricultural biotechnology customers.

The Belgian company recently received €3.6 million to develop the signature into a clinical test within the next three years.

NEW YORK (GenomeWeb) — Becton Dickinson's BD Diagnostics division announced this week the launch of the Total Nucleic Acid suite, a kit of reagents to enable DNA- and RNA-based assay development on the automated BD Max platform.

The US Food and Drug Administration has approved BioFire Diagnostics' FilmArray Blood Culture Identification Panel. BioFire said that the 27-target panel is the most comprehensive blood culture test to be approved by the FDA.

Luminex said this week that it has received clearance from the US Food and Drug Administration for its MagPix instrument and xTAG Gastrointestinal Pathogen Panel, or GPP.

BD Diagnostics, a division of Becton Dickinson, and Belgium's Diagenode this week announced the European launch of Diagenode's influenza A and B assay for use on the BD Max molecular testing system.

NEW YORK (GenomeWeb News) – Rubicon Genomics will integrate its ThruPlex technology into Diagenode's epigenetics platforms under a partnership announced today.

BGI and Diagenode will collaborate to develop standard methods in sample prep for next-generation sequencing for epigenetics research, the companies said today.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – BGI and Diagenode are collaborating to implement standard methods in epigenetics and next-generation sequencing sample preparation.

Pages

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.